Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RSV Vaccination in Bone Marrow Transplant and CAR-T Patients
NCT07296120Phase 4Not yet recruiting
- Sponsor
- Cooper University Health Care
- Start
- Jan 2026
- Primary completion
- Jan 2027
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of RSVpreF vaccine in respiratory syncytial virus infection (RSV), sponsored by Cooper University Health Care. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
RSVpreF vaccine
03
Conditions
respiratory syncytial virus infection (RSV)
Beyond the preview
Go deeper on NCT07296120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07296120.